"Reverse ageism" is actually a fairly controversial topic in biotech. After a Twitter debate, a top VC (and one of the only biotech VCs who blogs) wrote this post about why he likes older entrepreneurs [0]
IMO he has valid points, but there are all kinds of issues with his analysis, but bottom line is there isn't enough data to prove either sides point, so there's a lot of opinions presented as facts
IMO he has valid points, but there are all kinds of issues with his analysis, but bottom line is there isn't enough data to prove either sides point, so there's a lot of opinions presented as facts
[0] https://lifescivc.com/2018/02/grey-hair-c-suite-experience-a...